International Scholarly Research Notices

Research Article

Predictors of Survival in HIV-Infected Patient after Initiation of HAART in Zewditu Memorial Hospital, Addis Ababa, Ethiopia

Table 1

Sociodemographic, clinical, laboratory, substance use, and ART characteristics information of patients who started HHART in Zewditu Memorial Hospital, September 2008–February 2012.


Variable	Categories	Frequency	Mean survival in month	Percent (%)

Sex ()	Male	185	38.9	44.5
Sex ()	Female	231	40.3	55.5
Age of respondents ()	15–24	18	39.9	4.3
	25–34	181	39	43.5
	35–44	144	39.7	34.6
	>45	73	39.3	17.5
Marital status ()	Single	113	39.6	27.3
	Married	218	39.8	52.7
	Divorced	38	37.9	9.2
	Widowed	45	40.8	10.9
Educational status ()	No education	42	40.5	10.1
	Primary	151	39.6	36.5
	Secondary	155	40.5	37.3
	Tertiary & above	68	38.1	16.3
Religion ()	Protestant	45	39.3	10.8
	Orthodox	348	39.6	83.7
	Muslim	23	40.2	5.5
Cd4 count cell/µL	<50	63	36.9	16
Cd4 count cell/µL	≥50	330	40.3	84
BMI in kg/m²	<18.5	28	36.9	19.6
BMI in kg/m²	≥18.5	115	40.3	80.4
ART regimen	D4t-3TC-NVP	39	39.2	9.4
	D4T-3TC-EFV	11	32.8	2.6
	AZT-3TC-NVP	49	37.8	11.8
	AZT-3TC-EFV	92	41.2	22.1
	3TC-TDF-EF	225	39.5	54.01
Alcohol use	Nonusers	289	39.2	70.8
Alcohol use	Users	119	39.8	29.2
Tobacco use	Nonusers	323	39.6	78.6
Tobacco use	Users	88	39.1	21.4
Hard drug (iv drug, cocaine,…) use	Nonusers	378	39.6	91.7
Hard drug (iv drug, cocaine,…) use	Users	34	39.9	8.3
Soft drug (kchat, shisha) use	Nonusers	278	39.5	67
Soft drug (kchat, shisha) use	Users	137	40.8	33
WHO stage	Stage (1 & 2)	190	41.9	45.7
WHO stage	Stage (3 & 4)	226	37.9	54.3